Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Jul 19, 2019 at 6:25 AM EDT

Prader-Willi Syndrome Treatment Could Double Your Money in a Tiny Speculative Biotech

While this company is unknown by many investors, one analyst believes that this could be even better than a double-your-money…

Chris Lange | Jul 18, 2019 at 10:20 AM EDT

Why UnitedHealth Earnings Are Underwhelming

UnitedHealth reported its second-quarter financial results before the markets opened on Thursday.

Douglas A. McIntyre | Jul 18, 2019 at 10:17 AM EDT

It Will Be Dangerously Hot This Weekend in Most of US — Here Is How to Treat Heat Illness

This weekend will be a real scorcher in two-thirds of the United States. Some cities have already set up cooling…

Douglas A. McIntyre | Jul 18, 2019 at 10:17 AM EDT

A Major Heat Wave Will Take Over Most of US This Weekend — This Is How to Protect Yourself

A major heat wave will hit two-thirds of the United States this weekend and may come with potentially very serious…

Jon C. Ogg | Jul 18, 2019 at 7:20 AM EDT

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Johnson & Johnson shares took a hit after earnings, but it was more than just the earnings and guidance to…

Chris Lange | Jul 17, 2019 at 12:40 PM EDT

Why AvroBio Is Continuing Its Massive Run

AvroBio shares continued their run on Wednesday, despite the firm announcing that it would be conducting a secondary offering.

Chris Lange | Jul 17, 2019 at 10:20 AM EDT

Is There a Method to Inovio Pharma’s Cost-Cutting Madness?

Inovio Pharma shares dipped on Wednesday after the company said that it was taking measures to cut costs and its…

Jon C. Ogg | Jul 16, 2019 at 3:29 PM EDT

Why Johnson & Johnson Shareholders May Have to Ignore Earnings Looking Ahead

Johnson & Johnson shares traded lower despite beating earnings. It turns out that there are some issues outside of earnings…

Chris Lange | Jul 16, 2019 at 12:45 PM EDT

Tuesday’s Biggest Biotech Movers

24/7 Wall St. has picked a few biotech standouts from Tuesday to highlight. We have included information about each company,…

Chris Lange | Jul 16, 2019 at 10:20 AM EDT

Johnson & Johnson Slides By With Q2 Earnings

Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.

Chris Lange | Jul 15, 2019 at 3:29 PM EDT

Meet Gilead’s Newest Collaboration

Gilead and Galapagos each saw shares shoot up on Monday after the companies announced a new collaboration.

Chris Lange | Jul 15, 2019 at 12:55 PM EDT

What to Watch When Johnson & Johnson Reports Tomorrow

Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.

Chris Lange | Jul 15, 2019 at 11:05 AM EDT

Why Capricor May Be the Next Big Name in Duchenne Muscular Dystrophy

Capricor Therapeutics shares more than doubled on Monday after the firm announced interim analysis for its Duchenne muscular dystrophy midstage…

Chris Lange | Jul 15, 2019 at 9:55 AM EDT

Alkermes Looks to Expand Its Schizophrenia Treatment to Bipolar Patients

Alkermes shares made a handy gain on Monday after the firm announced that it would be expanding its New Drug…

Chris Lange | Jul 12, 2019 at 3:00 PM EDT

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data…

1 … 92 93 94 95 96 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Prader-Willi Syndrome Treatment Could Double Your Money in a Tiny Speculative Biotech

Why UnitedHealth Earnings Are Underwhelming

It Will Be Dangerously Hot This Weekend in Most of US — Here Is How to Treat Heat Illness

A Major Heat Wave Will Take Over Most of US This Weekend — This Is How to Protect Yourself

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Why AvroBio Is Continuing Its Massive Run

Is There a Method to Inovio Pharma’s Cost-Cutting Madness?

Why Johnson & Johnson Shareholders May Have to Ignore Earnings Looking Ahead

Tuesday’s Biggest Biotech Movers

Johnson & Johnson Slides By With Q2 Earnings

Meet Gilead’s Newest Collaboration

What to Watch When Johnson & Johnson Reports Tomorrow

Why Capricor May Be the Next Big Name in Duchenne Muscular Dystrophy

Alkermes Looks to Expand Its Schizophrenia Treatment to Bipolar Patients

Short Sellers Run for Cover From Major Biotechs

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Health and Healthcare Articles

All Health and Healthcare Articles

Prader-Willi Syndrome Treatment Could Double Your Money in a Tiny Speculative Biotech

Why UnitedHealth Earnings Are Underwhelming

It Will Be Dangerously Hot This Weekend in Most of US — Here Is How to Treat Heat Illness

A Major Heat Wave Will Take Over Most of US This Weekend — This Is How to Protect Yourself

5 Medtech Companies May Be Winning at Johnson & Johnson’s Expense

Why AvroBio Is Continuing Its Massive Run

Is There a Method to Inovio Pharma’s Cost-Cutting Madness?

Why Johnson & Johnson Shareholders May Have to Ignore Earnings Looking Ahead

Tuesday’s Biggest Biotech Movers

Johnson & Johnson Slides By With Q2 Earnings

Meet Gilead’s Newest Collaboration

What to Watch When Johnson & Johnson Reports Tomorrow

Why Capricor May Be the Next Big Name in Duchenne Muscular Dystrophy

Alkermes Looks to Expand Its Schizophrenia Treatment to Bipolar Patients

Short Sellers Run for Cover From Major Biotechs

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip